Medical expulsive therapy as an adjunct to improve shockwave lithotripsy outcomes: A systematic review and meta-analysis

Journal of Endourology

Volumn 23, Issue 3, 2009, Pages 387-393

  Schuler, Trevor D ^a   Shahani, Rohan ^a   Honey, R John D'A ^a   Pace, Kenneth T ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEFLAZACORT; METHYLPREDNISOLONE; NIFEDIPINE; PHYLLANTHUS NIRURI EXTRACT; PLACEBO; TAMSULOSIN; UNCLASSIFIED DRUG; URISTON;

ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; DRUG EFFECT; EXTRACORPOREAL LITHOTRIPSY; FOLLOW UP; HUMAN; LIBRARIAN; MEDLINE; META ANALYSIS; NEPHROLITHIASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; SYSTEMATIC REVIEW; URETER STONE; LITHOTRIPSY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME; UROLITHIASIS;

HUMANS; LITHOTRIPSY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; URINARY CALCULI;

EID: 65549138509     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2008.0216     Document Type: Article

References (24)

1. Preminger GM, Tiselius HG, Assimos DG, et al. 2007 Guideline for the management of ureteral calculi. J Urol 2007;178:2418-2434.
2. Albala DM, Assimos DG, Clayman RV, et al. Lower pole I: A prospective randomized trial of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy for lower pole nephrolithiasis - initial results. J Urol 2001;166:2072-2080.
3. Pearle MS, Lingeman JE, Leveillee R, et al. Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol 2005;173:2005-2009.
4. Pace KT, Ghiculete D, Harju M, Honey RJ; University of Toronto Lithotripsy Associates. Shock wave lithotripsy at 60 or 120 shocks per minute: A randomized, double-blind trial. J Urol 2005;174:595-599.
5. Chaussy C, Schmiedt E. Shock wave treatment for stones in the upper urinary tract. Urol Clin North Am 1983;10:743-750.
6. Kim FJ, Rice KR. Prediction of shockwave failure in patients with urinary tract stones. Curr Opin Urol 2006;16:88-92.
7. Pareek G, Hedican SP, Lee FT Jr, Nakada SY. Shock wave lithotripsy success determined by skin-to-stone distance on computed tomography. Urology 2005;66:941-944.
8. Pareek G, Armenakas NA, Panagopoulos G, Bruno JJ, Fracchia JA. Extracorporeal shock wave lithotripsy success based on body mass index and Hounsfield units. Urology 2005;65:33-36.
9. Semins MJ, Trock BJ, Matlaga BR. The effect of shock wave rate on the outcome of shock wave lithotripsy: A metaanalysis. J Urol 2008;179:194-197.
10. Pace KT, Tariq N, Dyer SJ, Weir MJ, D'A Honey RJ. Mechanical percussion, inversion and diuresis for residual lower pole fragments after shock wave lithotripsy: A prospective, single blind, randomized controlled trial. J Urol 2001;166:2065-2071.
11. The Cochrane Renal Group. www.cochrane-renal.org.
12. Bhagat SK, Chacko NK, Kekre NS, Gopalakrishnan G, Antonisamy B, Devasia A. Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteral calculi? J Urol 2007;177:2185-2188.
13. Gravina GL, Costa AM, Ronchi R, Galatioto GP, Angelucci A, Castellani D, Narcisi F, Vicentini C. Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology 2005;66:24-28.
14. Porpiglia F, Destefanis P, Fiori C, Scarpa RM, Fontana D. Role of adjunctive medical therapy with nifedipine and deflazacort after extracorporeal shock wave lithotripsy of ureteral stones. Urology 2002;59:835-838.
15. Micali S, Sighinolfi MC, Celia A, De Stefani S, Grande M, Cicero AF, Bianchi G. Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study. J Urol 2006;176:1020-1022.
16. Hollingsworth JM, Rogers MA, Kaufman SR, Bradford TJ, Saint S, Wei JT, Hollenbeck BK. Medical therapy to facilitate urinary stone passage: A meta-analysis. Lancet 2006;368: 1171-1179.
17. Crowley AR, Byrne JC, Vaughan ED Jr, Marion DN. The effect of acute obstruction on ureteral function. J Urol 1990;143:596-599.
18. Madeb R, Knopf J, Golijanin D, Bourne P, Erturk E. Evidence for alpha receptors in the human ureter. In: Evan AP, Lingeman JE, Williams JC Jr, eds. Renal Stone Disease: 1st Annual International Urolithiasis Research Symposium. Melville, New York: American Institute of Physics Conference Proceedings. 2007, vol 900, pp 253-260.
19. Ishigooka M, Nakada T, Hashimoto T, Iijima Y, Yaguchi H. Spinal substance P immunoreactivity is enhanced by acute chemical stimulation of the rat prostate. Urology 2002;59: 139-144.
20. Kinnman E, Nygards EB, Hansson P. Peripheral alphaadrenoreceptors are involved in the development of capsaicin induced ongoing and stimulus evoked pain in humans. Pain 1997;69:79-85.
21. Peters HJ, Eckstein W. Possible pharmacological means of treating renal colic. Urol Res 1975;3:55-59.
22. Andersson KE, Forman A. Effects of calcium channels blockers on urinary tract smooth muscle. Acta Pharmacol Toxicol 1986;58(suppl 2):193-200.
23. Hannappel J, Rohrmann D, Lutzeyer W. [Pharmacological modifications of ureteral activity]. (Ger) Urologe A 1986;25: 246-251.
24. O'Leary MP. Tamsulosin, current clinical experience. Urology 2001;58(suppl 1):42-48.